JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,454 | -97.5% | 10,319 | -94.7% | 0.00% | – |
| Q3 2022 | $452,000 | -21.5% | 193,496 | +1.7% | 0.00% | – |
| Q2 2022 | $576,000 | +689.0% | 190,173 | +1666.3% | 0.00% | – |
| Q1 2022 | $73,000 | -15.1% | 10,767 | +5.7% | 0.00% | – |
| Q4 2021 | $86,000 | -7.5% | 10,188 | -18.6% | 0.00% | – |
| Q3 2021 | $93,000 | +22.4% | 12,518 | +12.3% | 0.00% | – |
| Q2 2021 | $76,000 | -14.6% | 11,148 | -12.9% | 0.00% | – |
| Q4 2020 | $89,000 | -87.7% | 12,792 | -85.6% | 0.00% | – |
| Q3 2020 | $726,000 | -54.3% | 88,912 | -61.4% | 0.00% | -100.0% |
| Q2 2020 | $1,589,000 | +55.3% | 230,292 | +96.5% | 0.00% | – |
| Q4 2019 | $1,023,000 | – | 117,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |